Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
Authors:
- 1 September 2017
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 185, 53-62
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cellsBMC Cancer, 2013
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Emerging Tim-3 functions in antimicrobial and tumor immunityTrends in Immunology, 2011
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011
- Structure of mammalian AMPK and its regulation by ADPNature, 2011
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent MannerCell Metabolism, 2010
- The role of the Atg1/ULK1 complex in autophagy regulationCurrent Opinion in Cell Biology, 2010
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer modelBreast Cancer Research and Treatment, 2008
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisCancer Cell, 2006